CN1035333C - Production method of salinomycin and its sodium salt crystalline product - Google Patents
Production method of salinomycin and its sodium salt crystalline product Download PDFInfo
- Publication number
- CN1035333C CN1035333C CN92103152A CN92103152A CN1035333C CN 1035333 C CN1035333 C CN 1035333C CN 92103152 A CN92103152 A CN 92103152A CN 92103152 A CN92103152 A CN 92103152A CN 1035333 C CN1035333 C CN 1035333C
- Authority
- CN
- China
- Prior art keywords
- filter
- salinomycin
- add
- filtrate
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明为一种发酵液中提取盐霉素及其钠盐的工艺方法。将发酵液酸化后加入助滤剂过滤,滤渣用酒精萃取,过滤,滤液用活性炭脱色,过滤,取滤液浓缩,再加水,即得产品。本发明具有工艺简便、成本低,所用的溶剂毒性低等优点。The invention relates to a process for extracting salinomycin and its sodium salt from fermentation broth. Acidify the fermentation broth, add filter aid to filter, extract the filter residue with alcohol, filter, decolorize the filtrate with activated carbon, filter, take the filtrate to concentrate, and add water to obtain the product. The invention has the advantages of simple process, low cost, and low toxicity of the solvent used.
Description
本发明涉及一种从抗生素生物合成产物中提取抗生素结晶品的方法。The invention relates to a method for extracting antibiotic crystals from antibiotic biosynthesis products.
据文献报导,从发酵液中提取盐霉素结晶品的工艺方法有:According to literature reports, the technological method of extracting salinomycin crystalline product from fermented liquid has:
(一)美国专利3857948(1974年)(1) US Patent 3857948 (1974)
将发酵液过滤,滤渣中的菌丝体经自溶后用醋酸丁酯,丙酮和氯仿等有机溶剂萃取,萃取液经真空浓缩后用氧化铝柱层析提纯,用醋酸乙酯、正丁烷或二者的混合物洗脱,收集有活性的部分,真空浓缩后再经Sephadex LH-20层析,收集有效组份浓缩至干,即得盐霉素粉末。Filtrate the fermentation broth, extract the mycelia in the filter residue with organic solvents such as butyl acetate, acetone and chloroform after autolysis, concentrate the extract in vacuum and purify it with alumina column chromatography, and use ethyl acetate, n-butane Or the mixture of the two is eluted, the active part is collected, concentrated in vacuum and then chromatographed on Sephadex LH-20, the effective components are collected and concentrated to dryness to obtain salinomycin powder.
(二)日本专利 昭53-148595号:(2) Japanese Patent No. 53-148595:
培养液用稀释盐酸调pH为4.5~5,在60℃下搅拌10分钟,加4%(W/V)助滤剂,过滤,滤渣用醋酸丁酯抽提两次,提取液用5%碳酸钠水溶液50升洗涤,减压蒸干得粗粉,加100升正己烷溶解粗粉,减压浓缩至40升,置5℃下冷藏,得盐霉素钠粗品。经层析分离或用正己烷反复重结晶,得到纯的盐霉素钠。Adjust the pH of the culture solution to 4.5-5 with diluted hydrochloric acid, stir at 60°C for 10 minutes, add 4% (W/V) filter aid, filter, and extract the filter residue twice with butyl acetate, and extract the solution with 5% carbonic acid Wash with 50 liters of sodium aqueous solution, evaporate to dryness under reduced pressure to obtain coarse powder, add 100 liters of n-hexane to dissolve the coarse powder, concentrate under reduced pressure to 40 liters, and refrigerate at 5°C to obtain crude salinomycin sodium. After chromatographic separation or repeated recrystallization with n-hexane, pure salinomycin sodium can be obtained.
(三)抗生素 1982年第5期报导:向发酵液中加入4%的硅藻土,过滤,滤渣用1/2体积的醋酸丁酯提取两次,提取液用5%碳酸氢钠溶液充分洗涤,除去水相,有机层减压浓缩至油状物。将油状物用氧化铝柱层析,用醋酸乙醋∶甲醇(100∶0→100∶2→100∶20)洗脱,收集并合并对枯草杆菌有抑制活性的部分洗脱液,减压浓缩,浓缩物用硅胶柱层析,用氯仿∶甲醇(100∶0→100∶2→100∶20)洗脱,收集Rf值与盐霉素相近的组份,浓缩至干,于含水丙酮中重结晶,得白色盐霉素钠盐结晶品。(3) Antibiotics Reported in the fifth issue of 1982: add 4% diatomaceous earth to the fermentation broth, filter, extract the filter residue twice with 1/2 volume of butyl acetate, and fully wash the extract with 5% sodium bicarbonate solution , the aqueous phase was removed, and the organic layer was concentrated to an oil under reduced pressure. The oil was subjected to alumina column chromatography, eluting with ethyl acetate:methanol (100:0 → 100:2 → 100:20), collecting and combining the part of the eluate that had inhibitory activity against Bacillus subtilis, and concentrating under reduced pressure , the concentrate was chromatographed on a silica gel column, eluted with chloroform:methanol (100:0→100:2→100:20), and the components with Rf values similar to those of salinomycin were collected, concentrated to dryness, and reconstituted in aqueous acetone. Crystallization to obtain white salinomycin sodium salt crystals.
以上介绍的几种方法,所用的有机溶剂大多数都有毒性。由于发酵液中还含有相当大量的油,除丙酮外的其他有机溶剂在萃取盐霉素的同时也把油萃取到有机相中,进一步除油在工艺上是很麻烦的。采用丙酮虽然可以避免这一缺点,但丙酮沸点低,在生产过程中挥发损失较大。另外,用到层柱层来分离和反复进行重结晶都使生产工艺路线过长,很难实现工业化生产。Most of the organic solvents used in the methods described above are toxic. Because the fermentation broth also contains a considerable amount of oil, other organic solvents except acetone also extract the oil into the organic phase when extracting salinomycin, and further oil removal is very troublesome in technology. Although this shortcoming can be avoided by adopting acetone, acetone has a low boiling point and has a large volatilization loss in the production process. In addition, the separation and repeated recrystallization by layer and column make the production process route too long, and it is difficult to realize industrial production.
本发明的目的在于提供这样一种从盐霉素发酵液中提取盐霉素及其钠盐的工艺方法,它的生产工艺简捷,所用的溶剂毒性低,而且产品纯度和收得率高。The object of the present invention is to provide such a process for extracting salinomycin and its sodium salt from salinomycin fermentation broth, which has a simple and simple production process, low toxicity of solvents used, and high product purity and yield.
本发明是这样实现的:发酵液用酸酸化,调节pH1~6,加入硅藻土、草酸、黄白盐、硫酸锌等各种助滤剂1~5%,在真空或加压下过滤,弃去滤液,滤渣用低毒有机溶剂萃取,所用的低毒有机溶剂以醇类或丙酮为宜,最好使用酒精,然后在真空或加压下过滤,取滤液,加脱色剂如活性炭进行脱色,在真空或加压下过滤,取滤液浓缩,加适量水后即得盐霉素结晶。若滤液浓缩后先加碱调pH大于7,再加水,可得盐霉素钠结晶。The present invention is realized in the following way: acidify the fermented liquid with acid, adjust pH 1-6, add 1-5% of various filter aids such as diatomite, oxalic acid, yellow and white salt, zinc sulfate, etc., filter under vacuum or pressure, discard The filtrate is removed, and the filter residue is extracted with a low-toxic organic solvent. The low-toxic organic solvent used is preferably alcohol or acetone, preferably alcohol, and then filtered under vacuum or pressure, the filtrate is taken, and a decolorizing agent such as activated carbon is added for decolorization. Filtrate under vacuum or pressure, take the filtrate to concentrate, and add appropriate amount of water to obtain salinomycin crystals. If the filtrate is concentrated, add alkali to adjust the pH to greater than 7, and then add water to obtain salinomycin sodium crystals.
下面给出几个实施例:Several examples are given below:
一、发酵液100升,发酵单位为20000U/ml,加草酸调pH=1,过滤,滤渣加2倍量的酒精搅拌2小时,过滤,滤液加活性炭1公斤,搅拌后过滤,滤浓缩至约10升,加水20升,搅拌后静置,有结晶析出,过滤得到白色盐霉素结晶,烘干重1400克,收率70%。1. 100 liters of fermentation broth, the fermentation unit is 20000U/ml, add oxalic acid to adjust the pH=1, filter, add 2 times the amount of alcohol to the filter residue, stir for 2 hours, filter, add 1 kg of activated carbon to the filtrate, filter after stirring, filter and concentrate to about 10 liters, add 20 liters of water, stir and let it stand still, crystals precipitate out, filter to obtain white salinomycin crystals, dry weight 1400 grams, yield 70%.
二、发酵液100升,发酵单位2000U/ml,加盐酸调pH=1,加4%的硅藻土,搅拌10分钟,过滤,滤渣加三倍量酒精搅拌2小时,过滤,滤液加活性炭1公斤,搅拌后过滤,滤液浓缩至约10升,加水20升,搅拌后静置结晶,过滤得白色盐霉素结晶,烘干重1450克,收率72.5%。2. Fermentation broth 100 liters, fermentation unit 2000U/ml, add hydrochloric acid to adjust pH = 1, add 4% diatomaceous earth, stir for 10 minutes, filter, add three times the amount of alcohol to the filter residue, stir for 2 hours, filter, add activated carbon 1 to the filtrate kg, filtered after stirring, concentrated the filtrate to about 10 liters, added 20 liters of water, stirred and left to crystallize, filtered to obtain white salinomycin crystals, dried weight 1450 grams, yield 72.5%.
三、发酵液100升,发酵单位25000U/ml,加磷酸调pH=1,加黄血盐和硫酸锌各0.1公斤,加热至60℃,搅拌30分钟,过滤,滤渣加三倍量酒精搅拌2小时,过滤,滤液加活性炭1公斤,搅拌后过滤,滤液浓缩至约10升,浓缩液用碱调pH10,再加水20升,搅拌后静置结晶,过滤得白色盐霉素钠结晶。烘干重1480克,收得率74.1%。3. Fermentation broth 100 liters, fermentation unit 25000U/ml, add phosphoric acid to adjust pH = 1, add yellow blood salt and zinc sulfate 0.1 kg each, heat to 60°C, stir for 30 minutes, filter, add three times the amount of alcohol to the filter residue and stir for 2 hour, filter, add 1 kg of activated carbon to the filtrate, filter after stirring, concentrate the filtrate to about 10 liters, adjust the pH of the concentrated solution to 10 with alkali, add 20 liters of water, leave to stand for crystallization after stirring, and filter to obtain white salinomycin sodium crystals. The drying weight is 1480 grams, and the yield is 74.1%.
本发明的优点在于工艺较简单,不需层析分离和反复重结晶,就可以得到合格的结晶品。所用的工业酒精比文献介绍的方法所用的有机溶剂毒性低、价格也低一倍以上,整个过程地成本降低50%以上。The advantage of the invention is that the process is relatively simple, and qualified crystalline products can be obtained without chromatographic separation and repeated recrystallization. The industrial alcohol used is less toxic than the organic solvent used in the method introduced in the literature, and the price is more than twice as low, and the cost of the whole process is reduced by more than 50%.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN92103152A CN1035333C (en) | 1992-04-28 | 1992-04-28 | Production method of salinomycin and its sodium salt crystalline product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN92103152A CN1035333C (en) | 1992-04-28 | 1992-04-28 | Production method of salinomycin and its sodium salt crystalline product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1078263A CN1078263A (en) | 1993-11-10 |
| CN1035333C true CN1035333C (en) | 1997-07-02 |
Family
ID=4940046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN92103152A Expired - Fee Related CN1035333C (en) | 1992-04-28 | 1992-04-28 | Production method of salinomycin and its sodium salt crystalline product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1035333C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102702376A (en) * | 2012-05-24 | 2012-10-03 | 河北科技师范学院 | Process for extracting chestnut polysaccharide by pressurized solvent extraction method |
| CN104447789B (en) * | 2014-12-15 | 2018-09-14 | 山东齐发药业有限公司 | A kind of preparation method of Salinomycin Sodium fine work |
| CN104546739A (en) * | 2015-01-20 | 2015-04-29 | 山西新源华康化工股份有限公司 | Extraction process of salinomycin |
| CN105800828B (en) * | 2016-04-27 | 2019-07-23 | 滨海明鸿精细化工有限公司 | The recovery method of sodium pyrithione in a kind of waste water |
| CN108440558B (en) * | 2018-03-30 | 2019-04-09 | 内蒙古拜克生物有限公司 | A kind of method of purification of Salinomycin Sodium |
| CN108484630B (en) * | 2018-03-30 | 2019-03-05 | 内蒙古拜克生物有限公司 | A kind of salinomycin method of purification |
| CN108342426B (en) * | 2018-03-30 | 2019-01-01 | 内蒙古拜克生物有限公司 | A kind of method of fermenting and producing salinomycin |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857948A (en) * | 1972-03-03 | 1974-12-31 | Kaken Chemical Co | Salinomycin |
| JPS53148595A (en) * | 1977-06-01 | 1978-12-25 | Kaken Pharmaceut Co Ltd | Preparation of salinomycines |
-
1992
- 1992-04-28 CN CN92103152A patent/CN1035333C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857948A (en) * | 1972-03-03 | 1974-12-31 | Kaken Chemical Co | Salinomycin |
| JPS53148595A (en) * | 1977-06-01 | 1978-12-25 | Kaken Pharmaceut Co Ltd | Preparation of salinomycines |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1078263A (en) | 1993-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ297093B6 (en) | Process for isolating and purifying HMG-CoA reductase inhibitors | |
| CN110734467A (en) | method for extracting and purifying spinosad from fermentation liquor | |
| CN1035333C (en) | Production method of salinomycin and its sodium salt crystalline product | |
| CN101914098B (en) | Preparation method of Meropenem trihydrate crystals | |
| JP2002535996A (en) | Method for isolating pseudomonas acid A from culture solution containing pseudomonas acid group | |
| CN105859747B (en) | A kind of preparation method of cefepime Hydrochloride suitable for industrialized production | |
| CN116284254B (en) | Method for extracting high-purity high-content polymyxin B sulfate single component from fermentation liquor | |
| NO342269B1 (en) | Preparation and purification of mupirocin calcium | |
| CN101124221B (en) | Purification method of mupirocin | |
| KR20030043984A (en) | Method of purifying pravastatin or its pharmacologically acceptable salt | |
| CN110606844B (en) | Mupirocin purification method | |
| CN102453063B (en) | Method for separation of partricin B | |
| JP2873894B2 (en) | Cyclic depsipeptide and method for producing the same | |
| US6790984B1 (en) | Process for purifying pravastatin sodium from a fermentation broth | |
| EP1756055A1 (en) | Process for the purification of tryptophan | |
| CN113045611A (en) | Preparation method of high-purity lincomycin hydrochloride | |
| EP1286944B1 (en) | A solvent exchange process | |
| US6767998B2 (en) | Method for preparing purified erythromycin | |
| RU1822885C (en) | Method of isolation of 4- and/or 5-hydroxyindolyl-3-acetic acids | |
| KR100280367B1 (en) | Method for purification of fusidic acid | |
| JP2546239B2 (en) | Novel substance ovalicin | |
| JPS62293A (en) | Production of l-rhamnose | |
| CN106749569A (en) | A kind of isolation and purification method of PF1022A | |
| KR100471606B1 (en) | Precursor of Pravastatin, Pravastatin and Method for preparing the Same | |
| CN118894781A (en) | A method for separating and purifying chlorogenic acid from filter cake after flocculation of stevia extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
| OR01 | Other related matters | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |